| Literature DB >> 21712243 |
Sheona P Drummond1, John Hildyard, Helena Firczuk, Onrapak Reamtong, Ning Li, Shichina Kannambath, Amy J Claydon, Robert J Beynon, Claire E Eyers, John E G McCarthy.
Abstract
Dhh1 and Pat1 in yeast are mRNA decapping activators/translational repressors thought to play key roles in the transition of mRNAs from translation to degradation. However, little is known about the physical and functional relationships between these proteins and the translation machinery. We describe a previously unknown type of diauxic shift-dependent modulation of the intracellular locations of Dhh1 and Pat1. Like the formation of P bodies, this phenomenon changes the spatial relationship between components involved in translation and mRNA degradation. We report significant spatial separation of Dhh1 and Pat1 from ribosomes in exponentially growing cells. Moreover, biochemical analyses reveal that these proteins are excluded from polysomal complexes in exponentially growing cells, indicating that they may not be associated with active states of the translation machinery. In contrast, under diauxic growth shift conditions, Dhh1 and Pat1 are found to co-localize with polysomal complexes. This work suggests that Dhh1 and Pat1 functions are modulated by a re-localization mechanism that involves eIF4A. Pull-down experiments reveal that the intracellular binding partners of Dhh1 and Pat1 change as cells undergo the diauxic growth shift. This reveals a new dimension to the relationship between translation activity and interactions between mRNA, the translation machinery and decapping activator proteins.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21712243 PMCID: PMC3177209 DOI: 10.1093/nar/gkr474
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Strains used in this work
| Strain | Genotype | Source |
|---|---|---|
| PTC41 | DSMZ | |
| PTC92 | DSMZ | |
| PTC296 | DSMZ | |
| PTC324 | ( | |
| PTC325 | ( | |
| PTC326 | This study | |
| PTC327 | This study | |
| PTC326 | This study | |
| PTC327 | This study | |
| PTC328 | This study | |
| PTC329 | This study | |
| PTC330 | This study | |
| PTC331 | This study | |
| PTC332 | This study | |
| PTC333 | This study | |
| PTC334 | This study | |
| PTC335 | This study | |
| PTC336 | This study | |
| PTC337 | This study | |
| PTC348 | This study | |
| PTC349 | This study | |
| PTC340 | This study | |
| PTC341 | This study | |
| PTC347 | This study | |
| PTC349 | This study | |
| PTC350 | This study | |
| PTC351 | This study | |
| PTC389 | This study |
Plasmids used in this work
| Plasmid | Genotype | References |
|---|---|---|
| pJM23 | YEplac195- ade2-ura3 RPL25a:GFP | ( |
| pJM880 | YCplac33- RPS2:GFP | ( |
| pRP1502 | Pat1:GFP + Ycplac33 | ( |
| pRP1151 | Dhhh1:GFP LEU2 CEN | ( |
| pJM881 | YCp33- Supex2 RPS3:TCM | A. Stevenson and P. Juanes (this study) |
Figure 6.Subcellular localization of Dhh1-GFP in a ptet07::TEF2 (TEF1Δ) strain at different doxycycline levels. (A) Western blot showing repression of eIF4A expression by addition of different amounts of doxycycline. Relative expression levels of eIF4A were determined by labelling with a FITC-conjugated secondary antibody, followed by visualization with a Typhoon Biomolecular Imager (GE Healthcare) and analysis using ImageQuant software, using hexokinase as a loading control. The far-left lane (labelled DHH1::GFP) shows the expression levels of hexokinase and eIF4A in a control strain in which the DHH1::GFP fusion is transcribed from the natural chromosomal promoter. The other three lanes show, as labelled, 95% expression (0 ng/ml DOX—the promotor substitution induces a 5% decrease in expression level compared to wild-type), 70% (5 ng/ml DOX) and 50% (10 ng/ml DOX). (B) Cells were treated as in panel A and then grown to an OD600 = 0.5 (exponential) or OD600 = 2.0, were visualized on a Deltavision microscope and then 3D projections were generated from 50 serial Z-axis images collected at 0.1-micron intervals. (C) Cells expressing 95, 70 or 50% of the wild-type level of eIF4A were harvested during exponential (left) or retardation phase (diauxic growth shift; right) growth and extracts from these cells were then analysed by polysomal gradient fractionation. Corresponding polysomal gradient fractions were collected and proteins resolved by SDS–PAGE and probed using anti-GFP antibodies to determine the distribution of Dhh1-GFP.
Figure 2.Quantitation of cellular distributions of Dhh1-TCM or Pat1-TCM versus GFP-labelled 60S (rpL25-GFP), 40S (rps2-GFP), eIF4E, eIF4A, eEF3 or RF1. Graphical presentation of the degree of overlap of Dhh1-TCM or Pat1-TCM with ribosomal proteins and translation factors. The measurements for each tagging combination were obtained through analysis of a minimum of 10 cells, and the error bars represent the standard deviations.
Figure 3.Analysis of Dhh1, Pat1, eIF4A and Ded1 co-sedimentation across polysomal gradients. (A) The same number of cells in glucose-fermenting exponential phase or post-diauxic shift phase were extracted and proteins resolved by SDS–PAGE and western blotting to determine relative protein expression levels for the proteins indicated. (B) Polysomal gradient profiles and corresponding fractions were generated with either exponentially growing or post-diauxic shift cell cultures expressing either Dhh1-TCM or Pat1-TCM and protein distributions were determined by in-gel fluorescence (Dhh1-TCM and Pat1-TCM) or by western blotting (Ded1 and eIF4A). (C) Post-diauxic shift cell cultures expressing either Dhh1-GFP or Pat1-GFP were treated with RNase A or puromycin and polysomal gradient profiles and corresponding fractions were collected. Dhh1 and Pat1 distributions were determined using anti-GFP antibodies while Ded1 and eIF4A were identified using protein-specific polyclonal antibodies.
Figure 1.Subcellular localization of 40S, 60S, Dhh1 and Pat1 in exponentially growing and diauxic S. cerevisiae cells. (A) Fluorescence microscopy of glucose-fermenting exponentially growing yeast cells expressing combinations of Rpl25a-GFP or Rps2-GFP fusions and ReAsH-stained Dhh1-TCM or Pat1-TCM fusions. (B) The corresponding experiment to that shown in panel A with exponentially growing yeast cells expressing combinations of a ReAsH-stained Rps3-TCM fusion and Dhh1-GFP or Pat1-GFP fusions, respectively. (C) Cells expressing Dhh1-TCM or Pat1-TCM and Rpl25-GFP or Rps2-GFP were grown into the slower ethanol respiration-dependent growth phase (post-diauxic growth shift; OD600 = 2.0) and processed for imaging with the TCM-tagged protein labelled with ReAsH. Each image is a single slice montage of corresponding ReAsH, GFP and phase images. Overlap in the overlays in the bottom row is indicated by yellow staining. Scale bars = 5 μm.
Figure 4.Dhh1–TAP pull-downs reveal growth-phase-dependent associations between Dhh1, Pat1 and components of the translation machinery. (A) Exponentially growing cells (OD600 = 0.5) or post-diauxic shift cells (OD600 = 2.0) expressing TAP-tagged Dhh1 were processed as detailed in ‘Materials and Methods’ section and proteins complexed with Dhh1 were resolved by SDS–PAGE and visualized using SYPRORuby protein stain. These protein bands were excised and protein identities determined by LC–ESI–MS/MS as indicated. The asterisks indicate the positions of proteolytic products. (B) Dhh1–TAP complex purification was repeated with RNase A-treated cell extracts and probed using polyclonal antibodies.
Figure 5.Estimating relative protein abundance in fractions using LC–ESI–MS. (A) Graphical representation of emPAI scores for proteins associated with ribosomes. Each bar represents the average of three independent experiments, whereby the height of each bar is proportional to the magnitude of each average score (normalized to the sum of the average scores for fractions S2, P and S3 so as to reflect the proportion relative to the total emPAI scores for each protein; see Supplementary Figure S8). These values therefore represent relative proportions of each protein found in the respective fractions (expressed as fractions of 1.00). The rows correspond to the three respective fractions generated in the scheme shown in Supplementary Figure S7. (B) MASCOT values (detailed in Supplementary Figure S8) for the same data sets were calculated and plotted against the emPAI scores, revealing the degree of correlation between the two types of data.